Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRHI Magnesita Regulatory News (RHIM)

Share Price Information for RHI Magnesita (RHIM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3,785.00
Bid: 3,785.00
Ask: 3,815.00
Change: 20.00 (0.53%)
Spread: 30.00 (0.793%)
Open: 3,770.00
High: 3,825.00
Low: 3,770.00
Prev. Close: 3,765.00
RHIM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Indian subsidiary equity issuance

5 Apr 2023 17:00

RNS Number : 5367V
RHI Magnesita N.V.
05 April 2023
 

5 April 2023

 

RHI Magnesita N.V.

("RHI Magnesita" or "the Group")

 

Indian subsidiary equity issuance

 

RHI Magnesita announces the closing of an equity raise via the placing of new shares in its 60% owned subsidiary, RHI Magnesita India Limited ("RHIM India").

RHIM India has allocated 15,715,034 new shares (subject to finalization of basis of allotment) through a Qualified Institutional Placement ("QIP"), representing 8.4% of the existing paid-up issued share capital of RHIM India, at a price of ₹572.70 per share to raise gross proceeds of ₹9 billion (€101 million).

New shares issued via the QIP are expected to be admitted to trading on the National Stock Exchange of India Limited and the BSE Limited on or before 13 April 2023. HSBC Securities and Capital Markets (India) Private Limited acted as sole bookrunner on the QIP.

The Group also intends to subscribe for new shares via a Preferential Issue of ₹2 billion (€22 million), subject to the approval of the Board and shareholders of RHI Magnesita India.

Following the QIP and Preferential Issue, the Group will retain a shareholding of approximately 56% in RHIM India.

 

Ian Botha, Chief Financial Officer of RHI Magnesita, said: "We are pleased to have received strong support from Indian and foreign institutional investors for this equity raise in our subsidiary, RHI Magnesita India. The proceeds of the QIP will further broaden our sources of financing in the region and enable RHI Magnesita India to continue its development as the leading supplier of refractory products and services in what is the fastest growing refractory market globally."

 

For further enquiries, please contact:

Chris Bucknall, Head of Investor Relations

Tel +43 699 1870 6490

E‐mail: chris.bucknall@rhimagnesita.com

 

 

About RHI Magnesita

RHI Magnesita is the leading global supplier of high-grade refractory products, systems and solutions which are critical for high-temperature processes exceeding 1,200°C in a wide range of industries, including steel, cement, non-ferrous metals and glass. With a vertically integrated value chain, from raw materials to refractory products and full performance-based solutions, RHI Magnesita serves customers around the world, with around 13,500 employees in 33 main production sites and more than 70 sales offices. RHI Magnesita intends to leverage its leadership in terms of revenue, scale, product portfolio and diversified geographic presence to target strategically those countries and regions benefitting from more dynamic economic growth prospects.

The Group maintains a premium listing on the Official list of the London Stock Exchange (symbol: RHIM) and is a constituent of the FTSE 250 index, with a secondary listing on the prime segment of the Vienna Stock Exchange (Wiener Börse). For more information please visit: www.rhimagnesita.com

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (596/2014/EU).

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCUVSVROWUSRAR
Date   Source Headline
27th Jun 20184:23 pmRNSPress Speculation
26th Jun 20183:22 pmRNSRHI Magnesita: investment in China
7th Jun 20183:39 pmRNSLong Term Incentive Plan Awards
7th Jun 20182:49 pmRNSResult of AGM
5th Jun 20187:00 amRNSFuture Directorate Change
8th May 20187:00 amRNS1st Quarter Results
26th Apr 20184:35 pmRNSNotice of AGM
9th Apr 20184:08 pmRNSDirector/PDMR Shareholding
22nd Mar 20187:00 amRNSDividend Record Date
22nd Mar 20187:00 amRNSCompletion of Term Loan Refinancing
21st Mar 20187:00 amRNSAnnual Financial Report
28th Feb 20187:00 amRNSUPDATE ON THE INTEGRATED OFFER FOR MAGNESITA
31st Jan 20187:00 amRNSNotice of Redemption
16th Jan 20189:57 amRNSStefan Borgas new president of the WRA
28th Dec 201710:03 amRNSDirector/PDMR Shareholding
28th Dec 20177:00 amRNSPerpetual Bonds Partial Early Redemption
22nd Dec 20171:26 pmRNSDirector/PDMR Shareholding
21st Dec 201711:02 amRNSDirector/PDMR Shareholding
8th Dec 20176:06 pmRNSNOTIFICATION UNDER LISTING RULE 9.6.14R
6th Dec 20173:25 pmRNSDirector/PDMR Shareholding
5th Dec 201711:12 amRNSDirector/PDMR Shareholding
1st Dec 20177:00 amRNSCOMPLETION OF MERGER CONTROL DIVESTMENTS
30th Nov 201711:12 amRNSRHI Magnesita included in the FTSE 250 index
28th Nov 20178:00 amRNSRHI Magnesita acquires Agellis Group AB
21st Nov 20177:00 amRNSDirector/PDMR Shareholding
15th Nov 20174:46 pmRNSCompany Secretary Change
13th Nov 20177:00 amRNSTrading Update
2nd Nov 20175:40 pmRNSTotal Voting Rights
2nd Nov 20175:29 pmRNSDisclosure of Home Member State
30th Oct 201711:00 amRNSRHI Magnesita: chairman and CEO opened the market
27th Oct 20177:00 amRNSAdmission to the London Stock Exchange

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.